Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr (Q33224179)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr |
scientific article |
Statements
1 reference
Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr (English)
1 reference
Jaap Verweij
1 reference
Marijke Bontenbal
1 reference
Geert-Jan Creemers
1 reference
Hans J Braun
1 reference
Auke C de Boer
1 reference
Jos Th Janssen
1 reference
Rieneke B Leys
1 reference
Jan B Ruit
1 reference
Swan Hoo Goey
1 reference
Paul C van der Velden
1 reference
Leon G Kerkhofs
1 reference
Kristel L Schothorst
1 reference
Paul I Schmitz
1 reference
Hansje J Bokma
1 reference
Dutch Community Setting Trial for the Clinical Trial Group
1 reference
1 October 2005
1 reference
1 reference
23
1 reference
28
1 reference
7081-7088
1 reference
Identifiers
1 reference
1 reference